Page last updated: 2024-12-11

mastoparan

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID6324633
CHEMBL ID2370408
CHEMBL ID1964493
CHEBI ID78496
MeSH IDM0113455

Synonyms (21)

Synonym
nsc-351907
72093-21-1
mastoparan ,
nsc351907 ,
NCGC00163465-01 ,
mastoparan, vespula lewisii
CHEMBL2370408
chebi:78496 ,
ile-asn-leu-lys-ala-leu-ala-ala-leu-ala-lys-lys-ile-leu-nh2
inlkalaalakkil-nh2
l-isoleucyl-l-asparaginyl-l-leucyl-l-lysyl-l-alanyl-l-leucyl-l-alanyl-l-alanyl-l-leucyl-l-alanyl-l-lysyl-l-lysyl-l-isoleucyl-l-leucinamide
CHEMBL1964493 ,
AKOS024456455
mfcd00076865
mastoparan, vespula lewisii, >=97% (hplc), powder
mastoparan-l
Q27147837
ile-asn-leu-lys-ala-leu-ala-ala-leu-ala-lys-lys-ile-leunh2
nsc351907, 72093-21-1, chembl1964493, nsc-351907, ncgc00163465-01
mast cell degranulatingpeptide(vespula lewisii)
mastoparan (trifluoroacetate salt)

Research Excerpts

Overview

Mastoparan is a small peptide composed of 14 amino acid residues found in wasp venom. It is an invertebrate host defense peptide that penetrates lipid bilayers. Mastoparans have shown great potential as new drugs, and are excellent tools for the stu.

ExcerptReferenceRelevance
"Mastoparan (MpVT) is an α-helix and amphipathic tetradecapeptide obtained from"( In Silico and In Vitro Structure-Activity Relationship of Mastoparan and Its Analogs.
Daduang, S; Jangpromma, N; Klaynongsruang, S; Peigneur, S; Rungsa, P; Tytgat, J, 2022
)
1.69
"Mastoparan (MP) is an antimicrobial cationic tetradecapeptide with the primary structure INLKALAALAKKIL-"( Structure-Activity Relationship of New Chimeric Analogs of Mastoparan from the Wasp Venom
Mucha, P; Parfianowicz, B; Piechowicz, L; Rekowski, P; Ruczyński, J; Wiśniewska, K, 2022
)
2.41
"Mastoparan B (MP-B) is an amphiphilic peptide with a potent antimicrobial activity against most Gram-negative bacteria. "( Amphiphilic peptide Mastoparan-B induces conformational changes within the AdeB efflux pump, down-regulates adeB gene expression, and restores antibiotic susceptibility in an MDR strain of Acinetobacter baumannii.
Azizi, O; Ghaemi, MM; Modaresi, F; Shakibaie, MR; Tadjrobehkar, O, 2023
)
2.68
"Mastoparan is a small peptide composed of 14 amino acid residues found in wasp venom. "( Nuclear magnetic resonance studies on conformation and stability of mastoparan in methanol.
Miura, Y, 2021
)
2.3
"Mastoparan is a typical cationic and amphipathic tetradecapeptide found in wasp venom and exhibits potent biological activities. "( Evaluation of the bioactivity of a mastoparan peptide from wasp venom and of its analogues designed through targeted engineering.
Bininda-Emonds, ORP; Chen, T; Chen, X; Ma, C; Shaw, C; Wang, L; Wu, Y; Xi, X; Zhang, L; Zhou, M, 2018
)
2.2
"Mastoparan is an invertebrate host defense peptide that penetrates lipid bilayers, and we reasoned that a mastoparan analog might interact with the lipid component of virus membranes and thereby reduce infectivity of enveloped viruses."( A mastoparan-derived peptide has broad-spectrum antiviral activity against enveloped viruses.
Abraham, S; Barefoot, BE; Hudak, KE; Koci, MD; Ramsburg, EA; Sample, CJ; Staats, HF; Wanyonyi, MS, 2013
)
1.83
"Mastoparan is an α-helical and amphipathic tetradecapeptide obtained from the venom of the wasp Vespula lewisii. "( Mastoparan induces apoptosis in B16F10-Nex2 melanoma cells via the intrinsic mitochondrial pathway and displays antitumor activity in vivo.
Auada, AV; Barbuto, JA; Bydlowski, SP; de Azevedo, RA; de Sá-Junior, PL; Farias, CF; Ferreira, AK; Figueiredo, CR; Girola, N; Lebrun, I; Levy, D; Massaoka, MH; Matsuo, AL; Pasqualoto, KF; Rodrigues, CP; Travassos, LR, 2015
)
3.3
"Mastoparans are an abundant class of peptides in wasp venom and have shown great potential as new drugs, as well as being excellent tools for the study of G-protein-coupled receptors."( Antinociceptive properties of the mastoparan peptide Agelaia-MPI isolated from social wasps.
Alves, E; Biolchi, A; Gonçalves, J; Moreira, K; Mortari, M; Rangel, M; Silva, L, 2016
)
1.43
"Mastoparans are a family of small peptides identified from the venom of hymenopteroid insects. "( The mastoparanogen from wasp.
Lai, R; Li, J; Xu, X; Yang, H; Yu, H, 2006
)
2.33
"Mastoparan is an amphiphilic tetradecapeptide derived from wasp venom which activates G-proteins. "( Effects of mastoparan on a vascular contractility in rabbit aorta.
Ahn, DS; Choi, EJ; Kang, BS; Kang, SI; Lee, HY; Lee, YH, 1995
)
2.12
"Mastoparan is a cationic amphipathetic peptide that activates trimeric G proteins, and increases binding of the coat protein beta-COP to Golgi membranes. "( The G protein-activating peptide, mastoparan, and the synthetic NH2-terminal ARF peptide, ARFp13, inhibit in vitro Golgi transport by irreversibly damaging membranes.
Weidman, PJ; Winter, WM, 1994
)
2.01
"Mastoparan is a cationic, amphiphilic tetradecapeptide with an amidated carboxyl terminus."( Structural requirements of mastoparan for activation of membrane-bound guanylate cyclase.
Chang, CH; Chang, GD; Ho, CL; Song, DL, 1993
)
1.3
"Mastoparan (MP) is a component of wasp venom which stimulates secretion from a number of cell types. "( Mastoparan stimulates insulin secretion from pancreatic beta-cells by effects at a late stage in the secretory pathway.
Jones, PM; Mann, FM; Persaud, SJ; Wheeler-Jones, CP, 1993
)
3.17
"Mastoparan is a wasp venom peptide that activates G-proteins, certain classes of which are involved in the release of endothelium-derived relaxing factor (EDRF). "( Mechanism of mastoparan-induced EDRF release from pulmonary artery endothelial cells.
Peach, MJ; Tracey, WR,
)
1.94
"Mastoparan is a tetradecapeptide. "( Mastoparan activates apical chloride and potassium conductances, decreases cell volume, and increases permeability of cultured epithelial cell monolayers.
Carson, MR; Shasby, DM; Sheldon, RA; Winter, MC, 1992
)
3.17
"Mastoparan is a peptide component of wasp venom that increases nucleotide exchange in some classes of G alpha subunits of regulatory heterotrimeric GTP-binding proteins (G proteins)."( Evidence of a role for heterotrimeric GTP-binding proteins in endosome fusion.
Casey, PJ; Colombo, MI; Mayorga, LS; Stahl, PD, 1992
)
1
"Mastoparan is a 14-amino-acid peptide that stimulates secretion from several cell types. "( Characterization of a mastoparan-stimulated nucleotidase from bovine brain.
Denker, BM; Neer, EJ; Tempst, P, 1991
)
2.04
"Mastoparan is a unique stimulator of insulin release by the pancreatic islets, which acts through GTP-binding protein(s) and phospholipase A2."( Mastoparan, a wasp venom, stimulates insulin release by pancreatic islets through pertussis toxin sensitive GTP-binding protein.
Aizawa, T; Komatsu, M; Takeda, T; Yamada, T; Yokokawa, N, 1989
)
2.44

Effects

Mastoparan has been reported to induce a wide variety of cellular actions by activating GTP-binding proteins (G proteins) in various cells. Mastoparan inhibits the ADP-ribosylation of 20 kDa human platelet membrane proteins catalyzed by Clostridium botulinum exoenzyme C3.

ExcerptReferenceRelevance
"Mastoparan has been reported to induce a wide variety of cellular actions by activating GTP-binding proteins (G proteins) in various cells. "( Mastoparan-stimulated prolactin secretion in rat pituitary GH3 cells involves activation of Gq/11 proteins.
Ito, H; Kawashima, S; Uchino, K; Yajima, Y, 1997
)
3.18
"Mastoparan, which has been shown to active G proteins, inhibits the ADP-ribosylation of 20 kDa human platelet membrane proteins catalyzed by Clostridium botulinum exoenzyme C3 half-maximally and maximally (90%) at 20 and 100 microM concentrations, respectively. "( Interaction of mastoparan with the low molecular mass GTP-binding proteins rho/rac.
Aktories, K; Haberman, B; Just, I; Koch, G; Mohr, C, 1991
)
2.08

Actions

Mastoparan was able to increase the intracellular Ca2+ concentration in Fura-2-loaded individual lactotrophs. The mastoparan-induced [Cai] increase was also dependent on tyrosine phosphorylation since it was blocked by preincubation with genistein.

ExcerptReferenceRelevance
"The mastoparan-induced [Cai] increase was also dependent on tyrosine phosphorylation since it was blocked by preincubation with genistein."( Erythropoietin modulation of intracellular calcium: a role for tyrosine phosphorylation.
Bell, LL; Cheung, JY; Lynch, CJ; Miller, BA, 1994
)
0.77
"Mastoparan was able to increase the intracellular Ca2+ concentration in Fura-2-loaded individual lactotrophs."( Mastoparan, a wasp venom peptide, stimulates release of prolactin from cultured rat anterior pituitary cells.
Mau, SE; Vilhardt, H; Witt, MR, 1994
)
2.45
"Mastoparan did not inhibit ADP-ribosylation of the alpha subunit of Gs in the membrane fraction."( Pertussis toxin-insensitive effects of mastoparan, a wasp venom peptide, in PC12 cells.
Murayama, T; Nomura, Y; Oda, H, 1996
)
1.28
"Mastoparan, which can activate G-protein-linked phosphoinositide (PI)-signaling pathway through the activation of G proteins, stimulated a higher Ca2+ mobilization in macrophages from mice fed n-3 compared to n-6 fatty acids."( Alteration of platelet-activating factor-induced signal transduction in macrophages by n-3 fatty acids.
Chakrabarti, R; Erickson, KL; Hubbard, NE; Lim, D, 1997
)
1.02
"Mastoparan could increase [Ca2+]i even in the absence of extracellular Ca2+, but a larger increase was observed in the presence of extracellular Ca2+."( Mastoparan, a peptide toxin from wasp venom, stimulates glycogenolysis mediated by an increase of the cytosolic free Ca2+ concentration but not by an increase of cAMP in rat hepatocytes.
Matsubara, T; Tohkin, M; Yagami, T, 1990
)
2.44
"Mastoparan thus displays a novel mode of toxicity by acting directly on G proteins to mimic the role normally played by agonist-liganded receptors."( Mastoparan, a peptide toxin from wasp venom, mimics receptors by activating GTP-binding regulatory proteins (G proteins).
Higashijima, T; Nakajima, T; Ross, EM; Uzu, S, 1988
)
2.44
"Some mastoparans cause hemolysis and serotonin release from the platelets."( Wasp venom peptides; wasp kinins, new cytotrophic peptide families and their physico-chemical properties.
Fukuda, K; Miyazawa, T; Nakajima, T; Tsukamoto, Y; Uzu, S; Wakamatsu, K; Yasuhara, T, 1985
)
0.72

Treatment

ExcerptReferenceRelevance
"Mastoparan treatment produced rapid growth cone collapse and axonal retraction which persisted while MST was present."( Heterotrimeric G protein activation rapidly inhibits outgrowth of optic axons from adult and embryonic mouse, and goldfish retinal explants.
Bates, CA; Meyer, RL, 1996
)
1.02

Bioavailability

ExcerptReferenceRelevance
" However, the poor bioavailability of active pharmaceutical ingredients for bladder cancer cells on account of the biological barriers of bladder mucosa, together with significant side effects of currently used intravesical medicine, have limited the clinical outcomes of localized adjuvant therapy for bladder cancer."( Fluorinated Polymer Mediated Transmucosal Peptide Delivery for Intravesical Instillation Therapy of Bladder Cancer.
Cheng, Y; Deng, D; Lei, Q; Li, G; Liu, Z; Shen, W; Tian, L; Wang, F; Wang, S; Wu, S, 2019
)
0.51

Dosage Studied

Mastoparan is a known facilitator of phospholipase A2 enzymatic activity. The dose-response curve of mastoparan-induced histamine release from intact mast cells was shifted to the right by various concentrations of BAC.

ExcerptRelevanceReference
" Mastoparan, a known facilitator of phospholipase A2 enzymatic activity, shifted the bee venom phospholipase A2 dose-response curve to the left."( Inhibition of [3H]nitrendipine binding by phospholipase A2.
Goldman, ME; Pisano, JJ, 1985
)
1.18
" The dose-response curve of mastoparan-induced histamine release from intact mast cells was shifted to the right by various concentrations of BAC (C14)."( The mechanism of inhibition of alkylamines on the mast-cell peptidergic pathway.
Bronner, C; Fischer, T; Landry, Y; Mousli, M, 1993
)
0.58
"6 was calculated for galparan from a dose-response curve and Ki of 19."( Differential regulation of GTPase activity by mastoparan and galparan.
Langel, U; Pooga, M; Rezaei, K; Saar, K; Zorko, M, 1998
)
0.56
" In contrast to benzalkonium chloride, the dose-response curves for secretostatic and celltoxic effects of salmeterol markedly overlapped."( Influence of salmeterol and benzalkonium chloride on G-protein-mediated exocytotic responses of rat peritoneal mast cells.
Krebs, D; Seebeck, J; Ziegler, A, 2000
)
0.31
" Essentially no differences between wall-deficient and wild-type cells were observed with respect to dose-response and time-course of camptothecin and mastoparan."( The Cytotoxic Effects of Camptothecin and Mastoparan on the Unicellular Green Alga Chlamydomonas reinhardtii.
Morawski, M; Voigt, J; Wöstemeyer, J, 2017
)
0.92
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
antimicrobial agentA substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
mastoparansA group of cytoactive tetradecapeptide found in wasp venoms. They cause the degranulation of mast cells.
peptidyl amideA peptide that has a carbamoyl group at the C-terminus.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID81982-log of the half-maximal concentration for stimulation of GTPase in HL-60 membrane (sensitive to PTX)1997Journal of medicinal chemistry, Sep-12, Volume: 40, Issue:19
Alkyl-substituted amino acid amides and analogous di- and triamines: new non-peptide G protein activators.
AID81973Efficacy expressed as maximal stimulation of GTP hydrolysis in HL-60 membranes at a concentration 10 uM1997Journal of medicinal chemistry, Sep-12, Volume: 40, Issue:19
Alkyl-substituted amino acid amides and analogous di- and triamines: new non-peptide G protein activators.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (537)

TimeframeStudies, This Drug (%)All Drugs %
pre-199036 (6.70)18.7374
1990's267 (49.72)18.2507
2000's153 (28.49)29.6817
2010's66 (12.29)24.3611
2020's15 (2.79)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.13 (24.57)
Research Supply Index6.32 (2.92)
Research Growth Index5.21 (4.65)
Search Engine Demand Index50.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.18%)5.53%
Reviews24 (4.34%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other528 (95.48%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]